Guy R. Adami

Dr. Guy R. Adami

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NKNadia Kawar
Nadia Kawar
SPSeon Gyeong Park
Seon Gyeong Park
JSJoel L. Schwartz
Joel L. Schwartz
NCNicholas Callahan
Nicholas Callahan
AOAles Obrez
Ales Obrez
GAGuy R. Adami
Guy R. Adami
The effect of oral microbial composition on periodontal health and on systemic health has been, and is being established. The oral microbiome, in turn, can be altered by local and systemic diseases and conditions. Gastroesophageal reflux disease (GERD), has been associated with increased acidity in the oral cavity resulting in dental erosion, and controversially a reduced risk of periodontal disease. We hypothesized that presence of GERD was linked to a modified microbial profile in untreated GERD patients and that the use of proton pump inhibitor (PPI) drugs: potent disruptors of gut microbiome, in GERD patients might result in a salivary microbiome that is further distinct. Untreated GERD patients showed multiple differences in salivary microbiome as compared to healthy controls. Taxa found at lower levels related to the presence of GERD not treated by PPI included: Prevotella melaninogenica, Prevotella pallens, Leptotrichia, and Solobacterium moorei and thirteen others. In contrast, GERD patients chronically using PPI showed minimal differences in salivary taxa compared to healthy controls not using PPI.

4 October 2021 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
JSJoel L. Schwartz
Joel L. Schwartz
NPNatalia Peña
Natalia Peña
NKNadia Kawar
Nadia Kawar
AZAndrew Zhang
Andrew Zhang
NCNicholas Callahan
Nicholas Callahan
GAGuy R. Adami
Guy R. Adami
Background: Many factors can contribute to the exact makeup of the salivary microbiome. Differences in the oral microbiome occur with old age, which may be due to oral conditions and diseases associated with old age, such as edentulism, as well as other unknown causes. Methods: The salivary microbiome was sampled in patients from a large urban clinic. For all subjects age, gender, periodontal status, caries status, presence of edentulism, medications, and tobacco usage were recorded. Multifactor analysis was used to study variation in salivary microbiome profiles linked to these factors. Results: In the population sampled, there were significantly higher numbers of edentulous subjects, and increased levels of polypharmacy found with aging. Large differences in alpha diversity and beta diversity of the salivary microbiome in the old age group were largely linked to edentulism. However, multivariable analysis revealed, even after adjusting for differences in edentulism, polypharmacy, tobacco usage, periodontal disease, caries level, and gender, that old age itself was associated with lower levels of taxa Porphyromonas endodontalis, Alloprevotella tannerae, Filifactor alocis, Treponema, Lautropia Mirabilis and Pseudopropionibacterium sp._HMT_194. Surprisingly, of these taxa, most were ones known to reside on or near tooth surfaces. Conclusions: Another factor or factors beyond edentulism, polypharmacy and periodontal disease play a role in the differences seen in oral microbiome with old age. The nature of this factor(s) is not known.

18 September 2003 in Oncogene
Verified
Journal Article
Open access
PDF file
OKOlga A Kalinina
Olga A Kalinina
SKSergey A Kalinin
Sergey A Kalinin
EPEvelyne W Polack
Evelyne W Polack
IMIgor Mikaelian
Igor Mikaelian
SPSuchismita Panda
Suchismita Panda
GAGuy R. Adami
Guy R. Adami
Increased hepatic expression of the Forkhead transcription factor FoxM1B in adult mice accelerates hepatocyte proliferation after partial hepatectomy, while in hepatocytes in intact liver the transgenic (Tg) protein is inactive and has no effect on proliferation. To investigate the influence of FoxM1B on liver tumor formation, we examined the effect of sustained enrichment of FoxM1B in the hepatocytes of mice treated with a diethylnitrosamine (DEN)/phenobarbital tumor induction protocol. Tg enrichment of FoxM1B in hepatocytes did not increase the proliferation rate in normal liver tissue even when the protein was localized to the nucleus. However, it did cause an increase in the proliferation rate and size of preneoplastic and early neoplastic lesions, although having no effects on the total numbers of these lesions. As tumors progressed to hepatocellular carcinomas, the additional Tg FoxM1B protein had no effect on cell proliferation, and there was no increase in tumor burden compared to wild-type animals. This suggests that the artificial enrichment of FoxM1B in the liver, which has been suggested as a gene therapy protocol for liver dysfunction with aging, may not be tumorigenic in that organ.

18 January 2019 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
RGR. Kyle Gazdeck
R. Kyle Gazdeck
SFSarah R. Fruscione
Sarah R. Fruscione
GAGuy R. Adami
Guy R. Adami
YZYalu Zhou
Yalu Zhou
LCLyndon F. Cooper
Lyndon F. Cooper
JSJoel L. Schwartz
Joel L. Schwartz

26 July 2007 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
JSJoel L. Schwartz
Joel L. Schwartz
SPSuchismita Panda
Suchismita Panda
CBCraig Beam
Craig Beam
LBLaura E. Bach
Laura E. Bach
GAGuy R. Adami
Guy R. Adami

5 May 2011 in Oral Oncology
Verified
Journal Article
Closed access
AKAntonia Kolokythas
Antonia Kolokythas
JSJoel L. Schwartz
Joel L. Schwartz
KPKristen B. Pytynia
Kristen B. Pytynia
SPSuchismita Panda
Suchismita Panda
MYMike Yao
Mike Yao
GAGuy R. Adami
Guy R. Adami